Table 2 Demographic characteristics of patients for BMI SDS analysis^a

Age at GH start, years

n = 39

n = 59

n = 98

 Mean (SD)

7.95 (4.21)

3.98 (4.52)

5.56 (4.79)

 Median (range)

7.85 (2.04–17.56)

1.92 (0.39–17.66)

3.44 (0.39–17.66)

Female, %

62%

41%

49%

Baseline BA/CA ratio^b

n = 13

1.06 (0.17)

n = 13

0.79 (0.31)

n = 26

0.92 (0.28)

Final BA/CA ratio^b

n = 21

1.07 (0.17)

n = 27

0.88 (0.17)

n = 48

0.97 (0.19)

GH baseline dose, mg/kg/d

n = 39

0.03 (0.01)

n = 59

0.03 (0.01)

n = 98

0.03 (0.01)

GH final dose, mg/kg/d^b

n = 35

0.03 (0.01)

n = 56

0.03 (0.01)

n = 91

0.03 (0.01)

IGF-I SDS^b

n = 19

−0.46 (2.01)

n = 35

−0.87 (1.71)

n = 54

−0.72 (1.81)

Weight, kg

n = 39

38.89 (24.75)

n = 59

17.84 (18.61)

n = 98

26.21 (23.54)

Baseline height, cm

n = 39

119.6 (25.24)

n = 59

89.68 (28.29)

n = 98

101.6 (30.73)

Last recorded height, cm

n = 39

140.3 (21.25)

n = 59

122.4 (27.55)

n = 98

129.6 (26.61)

BMI, kg/m²

n = 39

24.68 (7.75)

n = 59

18.04 (4.90)

n = 98

20.68 (6.97)

Baseline BMI SDS

n = 39

1.80 (1.68)

n = 59

0.40 (1.54)

n = 98

0.96 (1.73)

Final BMI SDS

n = 39

1.88 (0.91)

n = 59

0.98 (1.83)

n = 98

1.34 (1.59)

Years of follow-up

n = 39

n = 59

n = 98

 Mean (SD)

2.28 (1.34)

2.56 (1.30)

2.45 (1.32)

 Median (range)

2.25 (0.06, 3.93)

3.09 (0.16, 3.98)

2.54 (0.06, 3.98)